Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | TSR-022 |
Trade Name | |
Synonyms | Cobolimab |
Drug Descriptions |
TSR-022 (Cobolimab) is monoclonal antibody that targets T-cell immunoglobulin and mucin domain-3 protein (TIM-3, HAVCR2), potentially resulting in enhanced anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | Immune Checkpoint Inhibitor 141 TIM-3 Antibody 8 |
CAS Registry Number | 2022215-65-0 |
NCIT ID | C128627 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Docetaxel + Dostarlimab-gxly + TSR-022 | Docetaxel Dostarlimab-gxly TSR-022 | 0 | 1 |
Dostarlimab-gxly + TSR-022 | Dostarlimab-gxly TSR-022 | 0 | 2 |
TSR-022 | TSR-022 | 0 | 1 |
TSR-022 + unspecified PD-1 antibody | TSR-022 unspecified PD-1 antibody | 0 | 1 |